Latest Given Imaging Ltd (GIVN) Headlines
Given Imaging Up 30.3% Since SmarTrend Uptrend Call (GIVN)
Comtex SmarTrend(R) - Wed Mar 12, 9:19AM CDT
SmarTrend identified an Uptrend for Given Imaging (NASDAQ:GIVN) on November 26th, 2013 at $23.00. In approximately 4 months, Given Imaging has returned 30.35% as of today's recent price of $29.98.
Given Imaging Has Returned 30.3% Since SmarTrend Recommendation (GIVN)
Comtex SmarTrend(R) - Tue Mar 04, 5:05PM CST
SmarTrend identified an Uptrend for Given Imaging (NASDAQ:GIVN) on November 26th, 2013 at $23.00. In approximately 3 months, Given Imaging has returned 30.35% as of today's recent price of $29.98.
Nasdaq stocks posting largest volume decreases
AP - Thu Feb 27, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
Shares of GIVN Up 30.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Feb 18, 9:44AM CST
SmarTrend identified an Uptrend for Given Imaging (NASDAQ:GIVN) on November 26th, 2013 at $23.00. In approximately 3 months, Given Imaging has returned 30.35% as of today's recent price of $29.98.
Covidien Looks Fully Valued
at The Street - Mon Feb 17, 5:30AM CST
While I'm willing to bet the company has several more quarters of exceptional growth ahead, I do believe the stock is fully valued here at around $72 per share.
3 Next-Generation Trends in Medical Tech You Need to Know
Dan Carroll, The Motley Fool - Motley Fool - Thu Feb 13, 1:54PM CST
Top medical device stocks steamed through 2013 and the market rally with flying colors, but it is innovation that will power the success of this industry in the future for investors. As established tech products such as defibrillators and pacemakers...
Uptrend Call Working As Given Imaging Stock Rises 30.3% (GIVN)
Comtex SmarTrend(R) - Mon Feb 10, 9:16AM CST
SmarTrend identified an Uptrend for Given Imaging (NASDAQ:GIVN) on November 26th, 2013 at $23.00. In approximately 3 months, Given Imaging has returned 30.35% as of today's recent price of $29.98.
FDA approves pill camera to screen colon
By MATTHEW PERRONE - AP - Mon Feb 03, 5:10PM CST
WASHINGTON (AP) — A kinder, gentler approach to one of the most dreaded exams in medicine is on the way: U.S. regulators have cleared a bite-size camera to help screen patients who have trouble with colonoscopies.
Given Imaging Ltd. Gets FDA Clearance for Colonoscopy Pill Camera
Patrick Morris, The Motley Fool - Motley Fool - Mon Feb 03, 2:39PM CST
Given Imaging announced today it has received clearance from the U.S. Food and Drug Administration (FDA) for its PillCam COLON camera that can be used for patients who have incomplete colonoscopies. "The clearance of PillCam COLON by the FDA...
Multimedia Release -- Given Imaging Receives FDA Clearance for PillCam(R) COLON in Patients Following Incomplete Colonoscopy
GlobeNewswire - Mon Feb 03, 12:00AM CST
PillCam COLON is the Only Non-Invasive and Radiation-Free Solution for the Approximately 750,000 Patients in the U.S. Who Experience an Incomplete Colonoscopy Each Year
Given Imaging Shares Up 30.2% Since SmarTrend's Buy Recommendation (GIVN)
Comtex SmarTrend(R) - Fri Jan 31, 4:59PM CST
SmarTrend identified an Uptrend for Given Imaging (NASDAQ:GIVN) on November 26th, 2013 at $23.00. In approximately 2 months, Given Imaging has returned 30.22% as of today's recent price of $29.95.
Given Imaging Announces Results of Special Shareholders' Meeting
GlobeNewswire - Thu Jan 23, 9:38AM CST
Given Imaging Ltd. (Nasdaq:GIVN) announced that at a special shareholders' meeting held today in Yoqneam, Israel, the shareholders of the Company approved the Merger Proposal described in the Proxy Statement dated December 24, 2013, including the merger between the Company and a subsidiary of Covidien Group S.a.r.l., a Luxembourg company and an indirect, wholly-owned subsidiary of Covidien plc, as a result of which the Company will become a wholly-owned subsidiary of Covidien.
Supporting More Women in Senior Roles
M2 - Fri Jan 17, 3:47AM CST
Ministry of Finance - Ontario is taking steps to ensure more women are represented on corporate boards and senior management teams in the province.
Imerjn Launches File Sharing and Cloud Storage Service
GlobeNewswire - Thu Jan 16, 5:00AM CST
Xumanii (DBA Imerjn) (OTCQB:XUII), announced that it has launched its file sharing service. The service will be accessible directly from the Imerjn website www.imerjn.com.
This Health Care Giant's Biggest Opportunity Isn't in America
Dan Carroll, The Motley Fool - Motley Fool - Wed Jan 15, 5:00PM CST
In an era when medical device companies face tough competition and pricing pressure in developed markets like the U.S. and Europe, emerging markets are a hot topic. Industry leaders Stryker and Medtronic have made big news in the past two years...
P & G Contributed CNY1.722bn Taxes to Shanghai in 2013
SinoCast - Wed Jan 15, 5:23AM CST
P & G (China) contributed taxes of CNY 1.722 billion to Shanghai in 2013, leaping 47 places in the list of Shanghai's top 100 taxpayers in 2012.
Conferences, Preliminary Revenues, Board Changes, Shareholders' Meeting Results, and Clinical Trial Initiation - Research Report on Antares, Quidel, bluebird bio, Given Imaging, and Immunomedics
PR Newswire - Tue Jan 14, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Antares Pharma, Inc. (NASDAQ: ATRS), Quidel Corporation (NASDAQ: QDEL), bluebird bio, Inc. (NASDAQ: BLUE), Given Imaging Ltd. (NASDAQ: GIVN), and Immunomedics, Inc. (NASDAQ: IMMU). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Given Imaging Up 30.3% Since SmarTrend Uptrend Call (GIVN)
Comtex SmarTrend(R) - Wed Mar 12, 9:19AM CDT
SmarTrend identified an Uptrend for Given Imaging (NASDAQ:GIVN) on November 26th, 2013 at $23.00. In approximately 4 months, Given Imaging has returned 30.35% as of today's recent price of $29.98.
Given Imaging Has Returned 30.3% Since SmarTrend Recommendation (GIVN)
Comtex SmarTrend(R) - Tue Mar 04, 5:05PM CST
SmarTrend identified an Uptrend for Given Imaging (NASDAQ:GIVN) on November 26th, 2013 at $23.00. In approximately 3 months, Given Imaging has returned 30.35% as of today's recent price of $29.98.
Nasdaq stocks posting largest volume decreases
AP - Thu Feb 27, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
Shares of GIVN Up 30.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Feb 18, 9:44AM CST
SmarTrend identified an Uptrend for Given Imaging (NASDAQ:GIVN) on November 26th, 2013 at $23.00. In approximately 3 months, Given Imaging has returned 30.35% as of today's recent price of $29.98.
Covidien Looks Fully Valued
at The Street - Mon Feb 17, 5:30AM CST
While I'm willing to bet the company has several more quarters of exceptional growth ahead, I do believe the stock is fully valued here at around $72 per share.
3 Next-Generation Trends in Medical Tech You Need to Know
Dan Carroll, The Motley Fool - Motley Fool - Thu Feb 13, 1:54PM CST
Top medical device stocks steamed through 2013 and the market rally with flying colors, but it is innovation that will power the success of this industry in the future for investors. As established tech products such as defibrillators and pacemakers...
Uptrend Call Working As Given Imaging Stock Rises 30.3% (GIVN)
Comtex SmarTrend(R) - Mon Feb 10, 9:16AM CST
SmarTrend identified an Uptrend for Given Imaging (NASDAQ:GIVN) on November 26th, 2013 at $23.00. In approximately 3 months, Given Imaging has returned 30.35% as of today's recent price of $29.98.
FDA approves pill camera to screen colon
By MATTHEW PERRONE - AP - Mon Feb 03, 5:10PM CST
WASHINGTON (AP) — A kinder, gentler approach to one of the most dreaded exams in medicine is on the way: U.S. regulators have cleared a bite-size camera to help screen patients who have trouble with colonoscopies.
Given Imaging Ltd. Gets FDA Clearance for Colonoscopy Pill Camera
Patrick Morris, The Motley Fool - Motley Fool - Mon Feb 03, 2:39PM CST
Given Imaging announced today it has received clearance from the U.S. Food and Drug Administration (FDA) for its PillCam COLON camera that can be used for patients who have incomplete colonoscopies. "The clearance of PillCam COLON by the FDA...
Multimedia Release -- Given Imaging Receives FDA Clearance for PillCam(R) COLON in Patients Following Incomplete Colonoscopy
GlobeNewswire - Mon Feb 03, 12:00AM CST
PillCam COLON is the Only Non-Invasive and Radiation-Free Solution for the Approximately 750,000 Patients in the U.S. Who Experience an Incomplete Colonoscopy Each Year
Given Imaging Shares Up 30.2% Since SmarTrend's Buy Recommendation (GIVN)
Comtex SmarTrend(R) - Fri Jan 31, 4:59PM CST
SmarTrend identified an Uptrend for Given Imaging (NASDAQ:GIVN) on November 26th, 2013 at $23.00. In approximately 2 months, Given Imaging has returned 30.22% as of today's recent price of $29.95.
Given Imaging Announces Results of Special Shareholders' Meeting
GlobeNewswire - Thu Jan 23, 9:38AM CST
Given Imaging Ltd. (Nasdaq:GIVN) announced that at a special shareholders' meeting held today in Yoqneam, Israel, the shareholders of the Company approved the Merger Proposal described in the Proxy Statement dated December 24, 2013, including the merger between the Company and a subsidiary of Covidien Group S.a.r.l., a Luxembourg company and an indirect, wholly-owned subsidiary of Covidien plc, as a result of which the Company will become a wholly-owned subsidiary of Covidien.
Supporting More Women in Senior Roles
M2 - Fri Jan 17, 3:47AM CST
Ministry of Finance - Ontario is taking steps to ensure more women are represented on corporate boards and senior management teams in the province.
Imerjn Launches File Sharing and Cloud Storage Service
GlobeNewswire - Thu Jan 16, 5:00AM CST
Xumanii (DBA Imerjn) (OTCQB:XUII), announced that it has launched its file sharing service. The service will be accessible directly from the Imerjn website www.imerjn.com.
This Health Care Giant's Biggest Opportunity Isn't in America
Dan Carroll, The Motley Fool - Motley Fool - Wed Jan 15, 5:00PM CST
In an era when medical device companies face tough competition and pricing pressure in developed markets like the U.S. and Europe, emerging markets are a hot topic. Industry leaders Stryker and Medtronic have made big news in the past two years...
P & G Contributed CNY1.722bn Taxes to Shanghai in 2013
SinoCast - Wed Jan 15, 5:23AM CST
P & G (China) contributed taxes of CNY 1.722 billion to Shanghai in 2013, leaping 47 places in the list of Shanghai's top 100 taxpayers in 2012.
Conferences, Preliminary Revenues, Board Changes, Shareholders' Meeting Results, and Clinical Trial Initiation - Research Report on Antares, Quidel, bluebird bio, Given Imaging, and Immunomedics
PR Newswire - Tue Jan 14, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Antares Pharma, Inc. (NASDAQ: ATRS), Quidel Corporation (NASDAQ: QDEL), bluebird bio, Inc. (NASDAQ: BLUE), Given Imaging Ltd. (NASDAQ: GIVN), and Immunomedics, Inc. (NASDAQ: IMMU). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
